Ocular Therapeutix (OCUL) Misses Q3 EPS by 1c

Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53). Revenue for the quarter came in at $523 thousand versus the consensus estimate of $510 thousand.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
• Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
• Capitol Federal Financial names William Skrobacz Jr. as president